Forty-one per cent of cancers detected by PSA screening can be classed as overdiagnosis, researchers say. Overdiagnosis of prostate cancer is a concern across the developed world, but researchers from Bond University say they are the first to quantify the problem in Australia.
More than 40 per cent of prostate cancers detected by basic screening tests are overdiagnosed in Australia, potentially leading to unnecessary treatments.
Professor Paul Glasziou, Bond University, says that we know that quite a lot of cancers are these dormant cancers that never would have disturbed the person in their lifetime... the most common complication would be impotence... Associate Professor David Smith, Cancer Council NSW, says we [...]
New Australian research suggests many men are being diagnosed with prostate cancer and potentially receiving unnecessary treatment. Bond University researchers have found too many men are getting invasive treatment, when more than 40 per cent of them wouldn't end up needing it.
The lifetime risk of being diagnosed with prostate cancer increased from 6.1% in 1982 (1 in 17) to 19.6% in 2012 (1 in 5). Using 2012 competing mortality rates, the lifetime risk in 1982 was 11.5% (95% CI 11.0% to 12.0%). The excess lifetime risk [...]
This stufy found a strong and apparently widely held desire for more information surrounding the topic of overdiagnosis and overtreatment. Careful consideration of how to inform both the public and current patients about the implications of a change in terminology, including changes to patients’ follow-up [...]
The childhood chant that "sticks and stones may break my bones but names can never harm me" is full of bravado but is not always right. It rushes over the emotional and social impact often caused by naming. This impact is at the centre of [...]
What health-related quality of life outcomes are associated with diagnosis and treatment of differentiated thyroid cancer and do they vary by type of surgery received? In this content analysis of survey responses of 1005 patients with differentiated thyroid cancer, 775 (77.1%) reported issues in their [...]
